Cargando…
Carbonic anhydrase IX as a novel candidate in liquid biopsy
Among the diagnostic techniques for the identification of tumour biomarkers, the liquid biopsy is considered one that offers future research on precision diagnosis and treatment of tumours in a non-invasive manner. The approach consists of isolating tumor-derived components, such as circulating tumo...
Autores principales: | Ozensoy Guler, Ozen, Supuran, Claudiu. T., Capasso, Clemente |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896409/ https://www.ncbi.nlm.nih.gov/pubmed/31790601 http://dx.doi.org/10.1080/14756366.2019.1697251 |
Ejemplares similares
-
Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection?
por: Deniz, Secil, et al.
Publicado: (2021) -
The inhibitory effect of boric acid on hypoxia-regulated tumour-associated carbonic anhydrase IX
por: Yusuf, Zainab Saad, et al.
Publicado: (2022) -
An Overview of the Bacterial Carbonic Anhydrases
por: Supuran, Claudiu T., et al.
Publicado: (2017) -
Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors
por: Kalinin, Stanislav, et al.
Publicado: (2021) -
Continued Structural Exploration of Sulfocoumarin as Selective Inhibitor of Tumor-Associated Human Carbonic Anhydrases IX and XII
por: Giovannuzzi, Simone, et al.
Publicado: (2022)